Navigation Links
Antihypertensive treatment on cognitive functions in Alzheimer's disease
Date:7/8/2008

Dementia is one of the major challenges of the 21st century due to the enormous burden these disorders impose on health care systems. Recently, common pathways of the two most frequent causes of dementia, Alzheimers disease and vascular dementia have been suggested. Today there is tremendous interest in developing effective treatments that will interfere with some step in the disease cascade or even prevent the clinical onset of dementia. In the absence of effective therapies, it is essential that all potentially reversible causes of dementia be fully investigated. So far no effective prevention measures can be recommended. During the last decade evidence has accumulated that high blood pressure (hypertension) may be a risk factor for dementia, independent of the presence of cerebrovascular disease. Treatment of hypertension thus might be a key factor in the prevention of cognitive decline and dementia. Dr. Ingmar Skoog, a renowned Swedish researcher in neuroscience from Gteborg University, will evaluate the latest findings about the effect of antihypertensive treatment on cognitive function and dementia and highlight a controversially discussed topic with broad impact on public health in all European countries: Is there hope for the prevention of dementia?


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
43-140-55734
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1

Related medicine news :

1. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
2. Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
3. New treatment effective in counteracting cocaine-induced symptoms
4. New treatment boosts muscle function in myasthenia gravis
5. Broad-based group of physicians calls for improvement in stroke treatment
6. Cranberry Could Juice Up Ovarian Cancer Treatment
7. Non-medicinal treatment touted for pre-schoolers with ADHD
8. Nonmedicinal treatment touted for preschoolers with ADHD
9. U of M study: Early treatment can reverse heart damage
10. Biologic treatment for rheumatoid arthritis and the risk of cancer
11. New Treatment Explored for Cluster Headaches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... ... communities, nine governmental public health departments have been awarded five-year accreditation status through ... that the benefits of being served by a PHAB-accredited health department now ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in Chicago, ... the life-sciences industry for ensuring label quality and improving patient safety. , ...
(Date:9/21/2017)... ... 2017 , ... Japanese Zen artist couple, Fumie and Kentaro Mune, have announced ... October at Miranda Kuo Gallery on Lower East Side, NYC. This exhibition will feature ... Wanderlust , one of the largest US yoga online media outlets in the ...
(Date:9/21/2017)... ... September 21, 2017 , ... Sagora Senior Living, one ... at Kingwood Assisted Living and Memory Care located at 24025 Kingwood Place Drive, ... assisted living apartments, 43 memory care apartments and 23 extended care apartments. Modern ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... center in Prescott, Arizona, is now accredited by The Joint Commission for chemical ... organization that accredits and certifies U.S. health care organizations that meet the commission’s ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 ... D.C. offering free MRI brain scans to the public.Where:  ... be parked at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide ...
(Date:9/9/2017)... INDIANAPOLIS , Sept. 9, 2017  Eli Lilly ... key primary and secondary endpoint data for lasmiditan, an ... migraine, which demonstrated statistically significant improvements compared to placebo ... be highlighted today at the 18th Congress of the ... . "The data presented today demonstrate lasmiditan,s ...
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life ... the Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful ... ... (PRNewsfoto/PharmaCareCard) ... http://pharmacarecard.com/ ...
Breaking Medicine Technology: